Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.32 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.32 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.32 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.32 |
| ▸ | CGAS | Q8N884 | 1/20 | 0.30 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.30 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30851802 | 0.98 | ALDH1A1 (0.32) | ALDH1A1L3MBTL1CASP3SENP8SENP7 | |
| SCHEMBL20818450 | 0.85 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1HCRTR1HCRTR2DPP4 | |
| SCHEMBL29900533 | 0.80 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1CASP3SENP8SENP7 | |
| SCHEMBL360266 | 0.80 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1CASP3SENP8SENP7 | |
| SCHEMBL28906832 | 0.79 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1CASP3SENP8SENP7 | |
| Hydrochloric Acid SCHEMBL1856795 | 0.78 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1CASP3SENP8SENP7 | |
| Hydrochloric Acid SCHEMBL1856799 | 0.78 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1CASP3SENP8SENP7 | |
| SCHEMBL20831662 | 0.75 | GABRA1 (0.37) | ALDH1A1L3MBTL1CASP3SENP8SENP7 | |
| SCHEMBL4670154 | 0.75 | L3MBTL1 (0.50) | ALDH1A1L3MBTL1CASP3SENP8SENP7 | |
| SCHEMBL27341970 | 0.75 | ALDH1A1 (0.36) | ALDH1A1L3MBTL1CASP3SENP8SENP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4587014-A2 | C5AR1 ANTAGONISTS AND USES THEREOF | Vanqua Bio, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2024059096-A2 | C5AR1 ANTAGONISTS AND USES THEREOF | VANQUA BIO, INC. (US) | 2024-03-21 | — | — | WO | disclosed |